An Indian pharmaceutical company is manufacturing unlicensed, highly addictive opioids and exporting them illegally to West ...

Innovative Chronic Pain Treatment Receives IP Protection in India's $55 Billion Pharmaceutical Market HERZLIYA, Israel and CALGARY, AB, Feb. 18, 2025 /PRNewswire/ -- Innocan Pharma ...

Strong early U.S. YORVIPATH® launch with 908 prescriptions as of Feb. 7, 2025; YORVIPATH full year 2024 revenue of €28.7 million - Following pre-NDA meeting with FDA, on track to submit TransCon CNP ...

Amity University Rajasthan successfully hosted E-SUMMIT 2025, a three-day mega event dedicated to fostering innovation, ...

In a report released today, Yun Zhong from Wedbush maintained a Buy rating on BioMarin Pharmaceutical (BMRN – Research Report), with a price ...

Silo Pharma (SILO) announced the filing of a provisional patent application with the USPTO for its lead asset SPC-15. Silo currently has ...

Originally scheduled for next week, the meeting of agency advisers will be delayed to give more time for public comment, according to an HHS spokesperson.

Nanoparticle characterization is vital for mRNA vaccine efficacy, ensuring safety and regulatory compliance in the ...

President Donald Trump says he wants to impose tariffs of 25% or more on imports of automobiles, semiconductor chips and ...

Julius Onah is the director behind Marvel’s Captain America: Brave New World , and in the “Special Thanks” credits, there was ...

Nvidia exited its positions in several AI stocks in Q4, but maintained its stake in Recursion Pharmaceuticals. Many investors seemed to view this as a vote of confidence from Nvidia for Recursion.